Articles by William Looney - Pharmaceutical Executive

ADVERTISEMENT

Articles by William Looney

The Night Stalkers: Keeping CEOs Awake in 2011

Feb 4, 2011

"Tops in Fraud" is a ruinous moniker for pharma—a business so dependent on basic issues of trust, integrity, quality and safety

Tracking the US Market: A Statistical Self-Portrait

Feb 1, 2011

What are some of the essential characteristics of the US market? Statistics drawn from the 2011 Statistical Abstract of the US shed some light

The Night Stalkers

Jan 1, 2011

"Tops in Fraud" is a ruinous moniker for pharma—a business so dependent on basic issues of trust, integrity, quality and safety

The San Diego Story

Jan 1, 2011

Building the commercial and policy base for effective collaboration in biotech

Emerging Stakeholders with Clout: The Press Power Behind ProPublica

Dec 1, 2010

The new investigative journalism organization recently took an in-depth look at pharma with its "Dollars for Docs" report. In return, Pharm Exec takes a look back at ProPublica

The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator

Dec 1, 2010

Outgoing EMA Director Thomas Lonngren discusses a decade at the helm of Europe's top regulatory office

In Through the Out Door

Dec 1, 2010

The end of anther year is an appropriate time to highlight the march of time—and the transitions that accompany it

Is Euroland Following the US Disclosure Lead?

Dec 1, 2010

Cegedim survey documents whether European industry is ready for the challenge of new compliance and disclosure risks on promotional spend

Pharma's Identity, From I to T

Nov 1, 2010

The FDA process itself is looking more like the unsavory 'sausage factory' associated with drafting partisan legislation

ADVERTISEMENT

Click here